Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Towa Pharmaceutical Co ( (JP:4553) ) has shared an update.
Towa Pharmaceutical Co., Ltd. has announced the financial results of its parent company, YOSHIDA JIMUSHO, for the fiscal year ending March 31, 2025. YOSHIDA JIMUSHO, which holds a 40.85% voting rights in Towa Pharmaceutical, is involved in investment, trading, leasing, and real estate management. This announcement provides insights into the financial health and strategic positioning of Towa Pharmaceutical’s parent company, potentially impacting stakeholders’ perceptions and the company’s future operations.
The most recent analyst rating on (JP:4553) stock is a Hold with a Yen3200.00 price target. To see the full list of analyst forecasts on Towa Pharmaceutical Co stock, see the JP:4553 Stock Forecast page.
More about Towa Pharmaceutical Co
Towa Pharmaceutical Co., Ltd. is a company based in Kadoma, Osaka, primarily engaged in the pharmaceutical industry. The company is focused on developing and manufacturing pharmaceutical products, with a significant market presence in Japan.
Average Trading Volume: 133,946
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen143.6B
Find detailed analytics on 4553 stock on TipRanks’ Stock Analysis page.